Physician

Mouhamed Walid Al Sheikha, MD

According to 2025 Medicare claims, Mouhamed Sheikha, MD (NPI: 1063418374) practices nephrology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is KIDNEY SPECIALISTS, PC (NPI: 1598935488; TIN: 61-1539474) and primary practice location at 52803-2467. Sheikha is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799), participating under the MSSP model.

Sheikha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,005 traditional Medicare patients, billed 7,210 HCPCS/CPT codes, and received $539,318 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 5,067 prescription claims across 469 beneficiaries totaling $480,964 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 96 claims. Open Payments data shows 17 records totaling $349. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $685,454 to $480,964. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $21,925 and ending at $16,272.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,680	19,123	$592,843
2016	2,573	16,913	$498,678
2017	2,953	18,055	$604,518
2018	2,507	8,433	$488,150
2019	2,451	7,674	$432,992
2020	1,925	7,715	$566,601
2021	2,077	7,589	$574,607
2022	2,086	7,200	$508,063
2023	1,988	6,996	$529,247
2024	2,005	7,210	$539,318

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	555	9,337	$685,454
2016	560	8,615	$712,669
2017	535	7,833	$666,763
2018	554	7,214	$544,737
2019	464	5,832	$461,300
2020	415	5,396	$406,891
2021	426	5,467	$431,559
2022	417	4,942	$456,479
2023	489	5,564	$554,745
2024	469	5,067	$480,964

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	92	431	$21,154
2016	55	323	$10,528
2017	42	287	$9,722
2018	63	368	$10,723
2019	48	332	$23,972
2020	25	178	$16,313
2021	21	115	$23,754
2022	17	100	$16,783
2023	187	245	$1,701,246
2024	N/R	96	$2,692

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	320	364	$126
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	407	2,979	$87
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	205	842	$57
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	204	259	$57
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,320	1,739	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	141	5,381	$100,640
Jardiance	Empagliflozin	98	3,201	$63,528
Kerendia	Finerenone	73	2,610	$55,686
Auryxia	Ferric Citrate	13	449	$40,315
Eliquis	Apixaban	16	918	$18,180

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	45	$1,485
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	14	$825
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	21	$293
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	16	$88

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$349	Baxter Healthcare
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mouhamed Walid Al Sheikha, MD?

Tedicare shows public-source Medicare data for Mouhamed Walid Al Sheikha, MD (NPI 1063418374), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mouhamed Walid Al Sheikha, MD have ACO affiliation data?

Mouhamed Walid Al Sheikha, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799).

What billing organization is linked to Mouhamed Walid Al Sheikha, MD?

Mouhamed Walid Al Sheikha, MD is linked to KIDNEY SPECIALISTS, PC (billing NPI 1598935488) in the available physician profile data.

Does Mouhamed Walid Al Sheikha, MD have Open Payments data?

Mouhamed Walid Al Sheikha, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.